ACE2 and COVID-19: In HeLa-ACE2 cells, a four-hour treatment of 20 μM tacrolimus did not reduce levels of IFITM2/3 (Supplemental Figure 5A), nor did it boost HIV-CoV-2 infection (Supplemental Figure 5B).